Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.

President-elect Donald Trump has talked a great deal about the economy and consumer ... that the Trump administration may be looking to make cuts to Social Security and Medicare. However, some Republican leaders have pushed back and said there would ...

Trump dismissed the order as part of what he called Biden’s “unpopular, inflationary, illegal, and radical practices.”

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.

President Donald Trump began his second administration with a blitz of policy actions to reorient U.S. government priorities.

President Donald Trump voided an executive order signed by former-President Joe Biden aimed at lowering prescription drug prices.

WASHINGTON (AP) — Donald Trump has promised sweeping actions in his ... Exempting those wages from payroll taxes would reduce the funding stream for Social Security and Medicare outlays. Trump has talked little about Medicaid during this campaign ...

The Democratic National Committee ( DNC) is going on the offense against President Donald Trump just two days into his second term, blasting the 45th and 47th President over what they say is a plan to follow through on the controversial Project 2025 agenda, including by cutting Social Security, Medicare and Medicaid.

On the first day of his second term, President Donald Trump signed an executive ... As of Jan. 23, 2025, Trump has not gotten rid of Medicare’s $35 cap on insulin prices, nor has he changed ...

The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department secretary to consider "new health care payment and delivery models" for the Center for Medicare and Medicaid Innovation to test.